-
61
-
62
The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease
Published 2017-03-01Subjects: Get full text
Article -
63
Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic revi...
Published 2025-02-01Subjects: “…GLP-1 receptor agonists…”
Get full text
Article -
64
“It’s a delicate balance”: clinicians’ experiences of providing heroin-assisted treatment
Published 2024-12-01Subjects: Get full text
Article -
65
Tirzepatide in Sport: A Comprehensive Review of its Metabolic Impacts and Potential Applications for Athletes
Published 2025-01-01Subjects: Get full text
Article -
66
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two ca...
Published 2025-02-01Subjects: “…thrombopoietin receptors agonists…”
Get full text
Article -
67
Incretin hormone agonists as promising antiobesity drugs - review of literature
Published 2025-01-01Subjects: Get full text
Article -
68
Targeting TCMR-associated cytokine genes for drug screening identifies PPARγ agonists as novel immunomodulatory agents in transplantation
Published 2025-01-01Subjects: Get full text
Article -
69
GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks
Published 2025-01-01Subjects: “…glucagon-like peptide-1 receptor agonists…”
Get full text
Article -
70
Sustained response off treatment after fostamatinib in refractory immune thrombocytopenia: A series of four case reports
Published 2025-12-01Subjects: “…thrombopoietin receptor agonists. TPO-RAs…”
Get full text
Article -
71
The combined effect of metformin and mirabegron on diet‐induced obesity
Published 2023-04-01Subjects: “…β3‐adrenergic receptor agonist…”
Get full text
Article -
72
Las pasiones en política. Emociones, democracia y populismo
Published 2024-08-01Subjects: Get full text
Article -
73
Enhanced renoprotective effects of combined glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors in type 2 diabetes mellitus: Real‐world evidence...
Published 2025-02-01Subjects: “…Glucagon‐like peptide‐1 receptor agonists…”
Get full text
Article -
74
-
75
Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice
Published 2025-01-01Subjects: “…GLP‐1 receptor agonists…”
Get full text
Article -
76
Efficacy and safety of glucagon-like peptide-1 receptor agonists in the elderly versus non-elderly patients with type 2 diabetes mellitus: insights from a systematic review
Published 2024-06-01Subjects: “…glucagon-like peptide-1 receptor agonists (glp-1ras)…”
Get full text
Article -
77
Comparison of hCG Versus Gonadotropin-Releasing Hormone Agonist to Induce Oocyte Maturation in Assisted Reproductive Technology Cycles: A Retrospective Cohort Study
Published 2021-08-01Subjects: “…GnRH agonist…”
Get full text
Article -
78
Managing cardiovascular events, hyperglycemia, and obesity in type 2 diabetes through microRNA regulation linked to glucagon-like peptide-1 receptor agonists
Published 2025-01-01Subjects: “…Glucagon-like peptide-1 receptor agonists…”
Get full text
Article -
79
Maintaining Fat-Free Mass and Muscle Mass during obesity therapy with Incretin-Mimetic Drugs
Published 2025-01-01Subjects: “…dual GLP-1/GIP receptor agonist…”
Get full text
Article -
80
Triple antiviral therapy in patient with liver cirrhosis: complications and options of pharmacological treatment
Published 2014-08-01Subjects: “…thrombopoietin receptors agonists…”
Get full text
Article